The 'LinkedIn' for Cancer – Newsweek

Researchers have often wondered why a drug that failed for virtually all test patients will trigger a miraculous recovery for a tiny sample during some drug trials. The answers may lie in DNA, and with new genome-sequencing technologies it may soon be …